Chenlei L. Shi - Publications

Retraction notice to "Investigating the mechanism of METTL16-dependent m6A modification regulating the SAMD11 protein signaling pathway to inhibit thyroid cancer phenotypes" [Int. J. Biol. Macromol. 280 (2024) 136176].

Journal: International journal of biological macromolecules

Published: July 29, 2026

Parathyroid autotransplantation into the brachioradialis protects parathyroid function during total thyroidectomy.

Journal: Frontiers in endocrinology

Published: April 10, 2026

Clinical effect analysis of endoscopic radical thyroidectomy via three-port gasless intermuscular approach

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: March 09, 2025

Investigating the mechanism of METTL16-dependent m6A modification regulating the SAMD11 protein signaling pathway to inhibit thyroid cancer phenotypes.

Journal: International journal of biological macromolecules

Published: August 01, 2024

Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 08, 2021

BRAFV600E mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features.

Journal: World journal of surgical oncology

Published: April 30, 2020

MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 26, 2018

Clinical pathological characteristics of resectable papillary thyroid microcarcinoma

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: May 25, 2017

Enhanced identification and functional protective role of carbon nanoparticles on parathyroid in thyroid cancer surgery: A retrospective Chinese population study.

Journal: Medicine

Published: November 19, 2016

Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.

Journal: PloS one

Published: June 21, 2016

Correlation between the BRAF V600E mutation status and the clinicopathologic features of papillary thyroid carcinoma.

Journal: Genetics and molecular research : GMR

Published: July 28, 2015

Pigment epithelium-derived factor has a role in the progression of papillary thyroid carcinoma by affecting the HIF1α-VEGF signaling pathway.

Journal: Oncology letters

Published: July 09, 2015